Axsome Surges As Its Newest Product Shines. But BioXcel Does The Opposite.Investors Business Daily • 05/08/23
Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate UpdateGlobeNewsWire • 05/08/23
Axsome Therapeutics to Present at the Bank of America Securities 2023 Healthcare ConferenceGlobeNewsWire • 05/03/23
Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health MonthGlobeNewsWire • 05/01/23
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy ofGlobeNewsWire • 04/21/23